| 000 | 02438 a2200661 4500 | ||
|---|---|---|---|
| 005 | 20250517132410.0 | ||
| 264 | 0 | _c20180222 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.14326 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhen, Mao-Chuan | |
| 245 | 0 | 0 |
_aIdentification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells. _h[electronic resource] |
| 260 |
_bOncotarget _cFeb 2017 |
||
| 300 |
_a9466-9475 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetates _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aAzocines _xpharmacology |
| 650 | 0 | 4 |
_aBenzhydryl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aBenzopyrans _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aInhibitor of Apoptosis Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMyeloid Cell Leukemia Sequence 1 Protein _xgenetics |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aProtein Stability |
| 650 | 0 | 4 | _aProteolysis |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRibosomal Protein S6 Kinases, 70-kDa _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTriazines _xpharmacology |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 |
_aUbiquitin-Protein Ligases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aX-Linked Inhibitor of Apoptosis Protein _xantagonists & inhibitors |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aWang, Fu-Qiang | |
| 700 | 1 | _aWu, Shao-Feng | |
| 700 | 1 | _aZhao, Yi-Lin | |
| 700 | 1 | _aLiu, Ping-Guo | |
| 700 | 1 | _aYin, Zhen-Yu | |
| 773 | 0 |
_tOncotarget _gvol. 8 _gno. 6 _gp. 9466-9475 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.14326 _zAvailable from publisher's website |
| 999 |
_c26742678 _d26742678 |
||